JA Fishman - The New England Journal of Medicine, 2007 - nejm.highwire.org Increasingly potent immunosuppressive agents have dramatically reduced the
incidence of rejection of transplanted organs while increasing patients'
susceptibility to opportunistic infections and cancer. 1 , 2 At the same ... Cited by 139 - Related articles - BL Direct - All 3 versions
JA Fishman, V Emery, R Freeman, M Pascual, L … - Clinical transplantation, 2007 - interscience.wiley.com Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT)
recipients causes both ''direct'' and ''indirect'' effects including allograft
rejection, decreased graft and patient survival, and predisposition to ... Cited by 66 - Related articles - BL Direct - All 4 versions
N Singh - Reviews in medical virology, 2006 - ingentaconnect.com Currently available, potent antiviral agents have proven highly effective for
the prevention of CMV disease during the time that prophylaxis is employed.
However, late-onset CMV disease, occurring in 5–18% of the patients, has ... Cited by 44 - Related articles - BL Direct - All 6 versions
- ►rima.org [PDF] LN Small, J Lau, DR Snydman - Clinical Infectious Diseases, 2006 - UChicago Press Featured in Toronto Star "Pigs, viruses and politics" May 2, 2009 Are Swine
Workers in the United States at Increased Risk of Infection with Zoonotic
Influenza Virus? Kendall P. Myers, Christopher W. Olsen, Sharon F. ... Cited by 44 - Related articles - BL Direct - All 5 versions
DR Snydman - Reviews in medical virology, 2006 - ingentaconnect.com Cytomegalovirus prevention strategies have been debated for the past decade.
This review argues in favour of the prophylaxis strategy. Clinical trials
comparing prophylaxis to pre-emptive therapy have, thus far, had ... Cited by 32 - Related articles - BL Direct - All 5 versions
AP Limaye, KA Kirby, GD Rubenfeld, WM … - Jama, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Cytomegalovirus ... Cited by 33 - Related articles - All 5 versions
V Kliem, L Fricke, T Wollbrink, M Burg, J … - American Journal of Transplantation, 2008 - medscape.com Oral ganciclovir prophylaxis and intravenous preemptive therapy are competitive
approaches to prevent cytomegalovirus (CMV) disease after renal transplantation.
This trial compared efficacy, safety and long-term graft outcome in 148 ... Cited by 28 - Related articles - BL Direct - All 7 versions
AY Peleg, S Husain, ZA Qureshi, FP Silveira, … - Clinical Infectious Diseases, 2007 - UChicago Press Featured in Reuters-USE_THIS "Dual HIV/TB infection common in S. African
infants" December 29, 2008 # High Incidence of Tuberculosis among HIV-Infected
Infants: Evidence from a South African Population-Based Study Highlights ... Cited by 27 - Related articles - BL Direct - All 4 versions
T Reischig, P Jindra, O Hes, M Svecova, J … - American Journal of Transplantation, 2008 - pt.wkhealth.com Both preemptive therapy and universal prophylaxis are used to prevent
cytomegalovirus (CMV) disease after transplantation. Randomized trials comparing
both strategies are sparse. Renal transplant recipients at risk for CMV ... Cited by 23 - Related articles - BL Direct - All 7 versions
FL Weng, AM Patel, R Wanchoo, Y Brahmbhatt … - Transplantation, 2007 - journals.lww.com Transplantation. Wolters Kluwer Health Logo. All Issues. ... Cited by 21 - Related articles - BL Direct - All 5 versions